These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1795000)

  • 21. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.
    Nanninga AG; de Vries EG; Willemse PH; Oosterhuis BE; Sleijfer DT; Hoekstra HJ; Mulder NH
    Eur J Cancer; 1991; 27(2):147-9. PubMed ID: 1827278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.
    Serrone L; Zeuli M; Papaldo P; Nardoni C; Pacetti U; Cognetti F
    Onkologie; 2001 Oct; 24(5):465-8. PubMed ID: 11694773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.
    Güllü I; Yalçin S; Tekuzman G; Barişta I; Alkiş N; Celik I; Zengin N; Güler N; Kars A; Baltali E
    Cancer Invest; 1996; 14(3):239-42. PubMed ID: 8630686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557).
    Klein HO; Wickramanayake PD; Christian E; Coerper C
    Cancer; 1984 Sep; 54(6 Suppl):1193-203. PubMed ID: 6432305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer.
    Gurney H; Harnett P; Stuart-Harris R; Kefford R
    Eur J Cancer; 1995 Oct; 31A(11):1773-7. PubMed ID: 8541098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas.
    Poorter RL; Bakker PJ; Huizing MT; Taat CW; Rietbroek RC; Gouma DJ; Rauws EA; Veenhof CH
    Ann Oncol; 1995 Dec; 6(10):1048-9. PubMed ID: 8750159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Nobile MT; Rosso R; Brema F; Cinquegrana A; Santi L
    Tumori; 1984 Oct; 70(5):433-7. PubMed ID: 6438851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J; Kellner R; Seeber S
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis.
    Bellmunt J; Eres N; Ribas A; Casado S; Albanell J; Baselga J
    Cancer Chemother Pharmacol; 1997; 40(3):273-6. PubMed ID: 9219513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?
    De Pas T; De Braud F; Orlando L; Nolè F; Munzone E; Zampino MG; Fazio N; Aapro MS; Goldhirsch A
    Ann Oncol; 1998 Aug; 9(8):917-9. PubMed ID: 9789617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
    Romaguera JE; Hagemeister FB; McLaughlin P; Rodriguez MA; Bachier C; Preti H; Sarris AH; Weber D; Younes A; Cabanillas F
    Leuk Lymphoma; 1998 Dec; 32(1-2):97-106. PubMed ID: 10037005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two schedules of application for mesna and their influence on the thiol-metabolism.
    Kempgens B; Kisro J; Gruber Y; Bahrs H; Wagner T
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):608-9. PubMed ID: 14692714
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
    Elias AD; Ayash LJ; Wheeler C; Schwartz G; Tepler I; McCauley M; Mazanet R; Schnipper L; Frei E; Antman KH
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):83-5. PubMed ID: 7992072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.